Chime Biologics

Chime Biologics was established in 2013 as the world's first modular biopharmaceutical manufacturing facility (GE KuBio). The facility is equipped with multiple 2,000 L, 500 L and 200 L single-use bioreactors for clinical and commercial GMP manufacturing and operated in compliance with US FDA, EMA, NMPA GMP standards.

We offer fully integrated CDMO services that enables robust, cost-effective and timely production of unrivalled quality therapeutics including monoclonal antibodies, bispecific antibodies, fusion proteins and enzymes from early-stage development through late-stage clinical and commercial manufacturing.